Table 1. Effects of recombinant gorilla adenovirus vaccine PRGN-2009 treatment on tumor immune cell infiltration in C57BL/6 mice bearing TC-1 (HPV16+) tumors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.